サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1637647

北米の皮膚フィラー市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別

North America Dermal Fillers Market Forecast to 2031 - Regional Analysis - by Product, Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate, Fat Fillers, and Others), Application, and End User

出版日
ページ情報
英文 80 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
北米の皮膚フィラー市場：2031年までの予測 - 地域別分析 - 製品別、材料別、用途別、エンドユーザー別
出版日: 2024年11月22日
発行: The Insight Partners
ページ情報: 英文 80 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の皮膚フィラー市場は、2023年に16億1,309万米ドルとなり、2031年までには28億7,429万米ドルに達すると予測され、2023年から2031年までのCAGRは7.5%と推定されます。

低侵襲処置への選好の高まりが北米の皮膚フィラー市場を後押し

低侵襲処置は、従来の外科的方法よりもいくつかの利点を提供するため、消費者の間で人気を得ています。これらの処置は、より少ないリスク、最小限の傷跡、より短い回復時間を含み、しばしば局所麻酔のみを必要とします。さらに、美容技術の進歩により、皮膚フィラーは以前よりも効果的で安全になりました。新しい処方のフィラーはより長持ちし、より自然な仕上がりになります。このことは、これらの施術に対する消費者の信頼を高め、その人気の高まりに貢献しています。美容学会の統計によると、米国では2022年に64万9,176件のフィラー施術が行われ、真皮フィラー施術は2022年の米国における非外科的総収入の14％を占めました。これは、2022年に最も一般的な非外科的美容手技の第3位となります。同様に、国際美容外科学会（ISAPS）の世界サーベイ2022報告書によると、2022年の非外科的および外科的美容施術の総数は、2021年と比較して11.2％増加し、世界中で1,490万件以上の外科的施術と1,880万件以上の非外科的施術が行われました。

さらに、医療・容施術の独自のニーズを決定する上で、年齢が重要な役割を果たしています。成人は低侵襲的なアプローチを好む傾向が強いです。さらに、35歳から55歳の人々は、手術よりも低侵襲の美容整形を好む傾向があります。形成外科医たちは、低侵襲美容術の探求にますます関心を寄せており、低侵襲美容術と美容術は、今や学際的なものと考えられています。非外科的技術や新しい治療法の進歩により、美容はより多くの人々にとって身近なものとなりました。20代から30代の患者がこの動向を牽引しています。

全体として、従来の手術よりも低侵襲な処置がもたらす利点と精度は、予測期間中も市場の成長を牽引し続けると予想されます。若々しさを保つことへの関心がますます高まっているため、様々な低侵襲皮膚科学技術が促進されています。美容皮膚科の分野は世界的に拡大しています。非外科的強化の人気がますます高まり、治療を受けた患者の数が増加するにつれて、フィラーの需要は増加し続け、北米の皮膚フィラー市場の成長を後押ししています。

北米の皮膚フィラー市場概要

北米の皮膚フィラー市場は、米国とカナダにおける市場企業の焦点の増加、高い一人当たりの支出、およびこの地域における有名な美容ブランドの存在により、大幅な成長を示すことが期待されています。同地域の消費者のライフスタイルの変化と多忙化により、多機能化粧品とパーソナルケア製剤の需要が増加しています。加えて、肥満のリスクやセルライトの蓄積による影響が、特殊な化粧品や美容施術に消費者を引き付けています。さらに、この地域には、しわがなく、にきびのない肌を手に入れたいと願う人口層が膨大に存在し、新しい美容施術の立ち上げに支えられています。

北米の皮膚フィラー市場の収益と2031年までの予測（金額）

北米の皮膚フィラー市場のセグメンテーション

北米の皮膚フィラー市場は、製品、材料、用途、エンドユーザー、国に分類されます。

製品に基づき、北米の皮膚フィラー市場は生分解性と非生分解性に二分されます。2023年には生分解性セグメントがより大きな市場シェアを占めています。

材料別では、北米の皮膚フィラー市場は、カルシウムハイドロキシアパタイト、ヒアルロン酸、コラーゲン、ポリ-L-乳酸、ポリメチルメタクリレート（PMMA）、脂肪フィラー、その他に分類されます。2023年にはヒアルロン酸セグメントが最大の市場シェアを占めました。

用途別では、北米の皮膚フィラー市場は、フェイスライン修正治療、リップ強化、フェイスリフト、傷跡治療、その他に区分されます。2023年にはリップ強化分野がより大きな市場シェアを占めています。

エンドユーザー別では、北米の皮膚フィラー市場は、多科目病院、皮膚科クリニック、外来手術センター、その他にセグメント化されます。2023年には皮膚科クリニックセグメントがより大きな市場シェアを占めています。

国別では、北米市場セグメンテーションは米国、カナダ、メキシコに区分されます。2023年の北米の皮膚フィラー市場シェアは米国が独占しました。

AbbVie Inc、Galderma SA、Merz Pharma GmbH &Co KGaA、Suneva Medical、TEOXANE LABORATORIES、Prollenium Medical Technologies、Sinclair Pharma Ltdは、北米の皮膚フィラー市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米の皮膚フィラー市場：主要市場力学

  • 市場促進要因
    • 低侵襲治療への選好の高まり
    • 美容と健康に対する消費者の魅力の高まり
  • 市場抑制要因
    • 皮膚フィラー施術の高コスト
  • 市場機会
    • 美容施術を目的とした医療ツーリズムの増加
  • 今後の動向
    • 併用療法の採用拡大
  • 促進要因と抑制要因の影響

第5章 皮膚フィラー市場：北米市場分析

  • 北米の皮膚フィラー市場収益、2021年～2031年
  • 北米の皮膚フィラー市場予測分析

第6章 北米の皮膚フィラー市場分析-製品別

  • 生分解性
  • 非生分解性

第7章 北米の皮膚フィラー市場分析-材料別

  • カルシウムハイドロキシアパタイト
  • ヒアルロン酸
  • コラーゲン
  • ポリ乳酸
  • ポルメチルメタクリレート（PMMA）
  • 脂肪フィラー
  • その他

第8章 北米の皮膚フィラー市場分析-用途別

  • フェイスライン修正治療
  • 唇の強化
  • フェイスリフト
  • 傷跡治療
  • その他

第9章 北米の皮膚フィラー市場分析-エンドユーザー別

  • 多科目病院
  • 皮膚科クリニック
  • 外来手術センター
  • その他

第10章 北米の皮膚フィラー市場：国別分析

  • 米国
  • カナダ
  • メキシコ

第11章 皮膚フィラー市場：業界情勢

  • 皮膚フィラー市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 皮膚フィラー市場-競合情勢

  • 主要企業によるヒートマップ分析
  • 企業のポジショニングと集中度-企業シェア分析-2022年
  • 企業製品収益

第13章 企業プロファイル

  • AbbVie Inc
  • Galderma SA
  • Merz Pharma GmbH & Co KGaA
  • Suneva Medical
  • TEOXANE LABORATORIES
  • Prollenium Medical Technologies
  • Sinclair Pharma Ltd

第14章 付録

図表

List Of Tables

  • Table 1. North America Dermal Fillers Market Segmentation
  • Table 2. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 4. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 5. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 7. North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 8. US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 9. US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 10. US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 11. US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 12. Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 13. Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 14. Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 15. Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 16. Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 17. Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Material
  • Table 18. Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 19. Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. Recent Organic Growth Strategies in Dermal Fillers Market
  • Table 21. Recent Inorganic Growth Strategies in the Dermal Fillers Market

List Of Figures

  • Figure 1. North America Dermal Fillers Market Segmentation, by Country
  • Figure 2. North America Dermal Fillers Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Dermal Fillers Market Revenue (US$ Million), 2021-2031
  • Figure 5. North America Dermal Fillers Market Share (%) - by Product (2023 and 2031)
  • Figure 6. Biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Non-biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. North America Dermal Fillers Market Share (%) - by Material (2023 and 2031)
  • Figure 9. Calcium Hydroxylapatite: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Hyaluronic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Collagen: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poly-L-Lactic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Polmethylmethacrylate (PMMA): North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Fat Fillers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. North America Dermal Fillers Market Share (%) - by Application (2023 and 2031)
  • Figure 17. Facial Line Correction Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Lip Enhancement: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Face Lift: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Scar Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. North America Dermal Fillers Market Share (%) - by End User (2023 and 2031)
  • Figure 23. Multispecialty Hospitals: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Dermatology Clinics: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Ambulatory Surgical Centers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. North America Dermal Fillers Market Breakdown, by Key Countries - 2023 (US$ Million)
  • Figure 28. North America Dermal Fillers Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 29. US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Growth Strategies in Dermal Fillers Market
目次
Product Code: TIPRE00025241

The North America dermal fillers market was valued at US$ 1,613.09 million in 2023 and is expected to reach US$ 2,874.29 million by 2031; it is estimated to register a CAGR of 7.5% from 2023 to 2031.

Increasing Preference for Minimally Invasive Procedures Fuels North America Dermal Fillers Market

Minimally invasive procedures have gained popularity among consumers, as they offer several advantages over traditional surgical methods. These procedures involve less risk, minimal scarring, shorter recovery times, and often require only local anesthesia. Additionally, advancements in cosmetic techniques have made dermal fillers more effective and safer than ever before. Newer formulations of fillers are longer-lasting and provide more natural-looking results. This has increased consumer confidence in these procedures and contributed to their growing popularity. According to the statistics from the Aesthetic Society, 649,176 filler procedures were performed in the US in 2022, and dermal filler procedures accounted for 14% of the total nonsurgical revenue in the US in 2022. This makes it the third most common nonsurgical aesthetic procedure in 2022. Similarly, according to the Global Survey 2022 report by the International Society of Aesthetic Plastic Surgery (ISAPS), the total number of nonsurgical and surgical aesthetic procedures increased by 11.2% in 2022 compared to 2021, with more than 14.9 million surgical and 18.8 million nonsurgical procedures performed worldwide.

Furthermore, age plays a substantial role in determining the unique needs of medical aesthetic procedures; adults are more inclined toward minimally invasive approaches. Furthermore, people aged 35-55 have a preference for minimally invasive cosmetic procedures over surgery. Plastic surgeons are increasingly interested in exploring them, and minimally invasive cosmetic and aesthetic procedures are now considered interdisciplinary. The advancement of nonsurgical technologies and new treatment alternatives has made aesthetics more accessible to a wider population. Patients in their 20s and 30s are driving this trend.

Overall, the benefits and accuracy offered by minimally invasive procedures over traditional surgery are expected to continue to drive the market growth during the forecast period. The ever-increasing interest in retaining a youthful appearance has facilitated various minimally invasive dermatological techniques. The field of cosmetic dermatology has been expanding globally. With the ever-increasing popularity of nonsurgical enhancement and an increasing number of patients who have been treated, the demand for fillers continues to rise, boosting the North America dermal fillers market growth.

North America Dermal Fillers Market Overview

North America dermal fillers market is expected to witness substantial growth owing to the increasing focus of market players in the US and Canada, high per capita spending, and the presence of renowned beauty brands in the region. The changing and busy lifestyles of consumers in the region have led to a rise in the demand for multifunctional cosmetics and personal care formulations. In addition, the obesity risk and implications caused by cellulite accumulation have attracted consumers toward special cosmetic and beauty procedures. Moreover, the region has a huge population base willing to get wrinkle-free and acne-free skin, backed up by the launch of new beauty procedures.

North America Dermal Fillers Market Revenue and Forecast to 2031 (US$ Million)

North America Dermal Fillers Market Segmentation

The North America Dermal Fillers Market is categorized into product, material, application, end user, and country.

Based on product, the North America Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held a larger market share in 2023.

In terms of material, the North America Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held the largest market share in 2023.

By application, the North America Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held a larger market share in 2023.

By end user, the North America Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held a larger market share in 2023.

By country, the North America Dermal Fillers Market is segmented into the US, Canada, and Mexico. The US dominated the North America Dermal Fillers Market share in 2023.

AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, TEOXANE LABORATORIES, Prollenium Medical Technologies, and Sinclair Pharma Ltd are some of the leading companies operating in the North America Dermal Fillers Market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Dermal Fillers Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Preference for Minimally Invasive Procedures
    • 4.1.2 Rising Attraction of Consumers Toward Beauty and Wellness
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Dermal Filler Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Growing Medical Tourism for Cosmetic Procedures
  • 4.4 Future Trends
    • 4.4.1 Growing Adoption of Combination Therapies
  • 4.5 Impact of Drivers and Restraints:

5. Dermal Fillers Market - North America Market Analysis

  • 5.1 North America Dermal Fillers Market Revenue (US$ Million), 2021-2031
  • 5.2 North America Dermal Fillers Market Forecast Analysis

6. North America Dermal Fillers Market Analysis - by Product

  • 6.1 Biodegradable
    • 6.1.1 Overview
    • 6.1.2 Biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Non-biodegradable
    • 6.2.1 Overview
    • 6.2.2 Non-biodegradable: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Dermal Fillers Market Analysis - by Material

  • 7.1 Calcium Hydroxylapatite
    • 7.1.1 Overview
    • 7.1.2 Calcium Hydroxylapatite: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Hyaluronic Acid
    • 7.2.1 Overview
    • 7.2.2 Hyaluronic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Collagen
    • 7.3.1 Overview
    • 7.3.2 Collagen: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Poly-L-Lactic Acid
    • 7.4.1 Overview
    • 7.4.2 Poly-L-Lactic Acid: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Polmethylmethacrylate (PMMA)
    • 7.5.1 Overview
    • 7.5.2 Polmethylmethacrylate (PMMA): North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Fat Fillers
    • 7.6.1 Overview
    • 7.6.2 Fat Fillers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Dermal Fillers Market Analysis - by Application

  • 8.1 Facial Line Correction Treatment
    • 8.1.1 Overview
    • 8.1.2 Facial Line Correction Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Lip Enhancement
    • 8.2.1 Overview
    • 8.2.2 Lip Enhancement: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Face Lift
    • 8.3.1 Overview
    • 8.3.2 Face Lift: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Scar Treatment
    • 8.4.1 Overview
    • 8.4.2 Scar Treatment: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Dermal Fillers Market Analysis - by End User

  • 9.1 Multispecialty Hospitals
    • 9.1.1 Overview
    • 9.1.2 Multispecialty Hospitals: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Dermatology Clinics
    • 9.2.1 Overview
    • 9.2.2 Dermatology Clinics: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Overview
    • 9.3.2 Ambulatory Surgical Centers: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: North America Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Dermal Fillers Market - Country Analysis

  • 10.1 North America Dermal Fillers Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 North America Dermal Fillers Market - Revenue and Forecast Analysis - by Country
    • 10.1.2 US Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.2.1 US Dermal Fillers Market Breakdown, by Product
      • 10.1.2.2 US Dermal Fillers Market Breakdown, by Material
      • 10.1.2.3 US Dermal Fillers Market Breakdown, by Application
      • 10.1.2.4 US Dermal Fillers Market Breakdown, by End User
    • 10.1.3 Canada Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.3.1 Canada Dermal Fillers Market Breakdown, by Product
      • 10.1.3.2 Canada Dermal Fillers Market Breakdown, by Material
      • 10.1.3.3 Canada Dermal Fillers Market Breakdown, by Application
      • 10.1.3.4 Canada Dermal Fillers Market Breakdown, by End User
    • 10.1.4 Mexico Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
      • 10.1.4.1 Mexico Dermal Fillers Market Breakdown, by Product
      • 10.1.4.2 Mexico Dermal Fillers Market Breakdown, by Material
      • 10.1.4.3 Mexico Dermal Fillers Market Breakdown, by Application
      • 10.1.4.4 Mexico Dermal Fillers Market Breakdown, by End User

11. Dermal Fillers Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Dermal Fillers Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Dermal Fillers Market - Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration - Company Share Analysis - 2022
  • 12.3 Company Product Revenue

13. Company Profiles

  • 13.1 AbbVie Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Galderma SA
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Merz Pharma GmbH & Co KGaA
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Suneva Medical
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 TEOXANE LABORATORIES
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Prollenium Medical Technologies
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Sinclair Pharma Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners